Evidence map›Paper›PMID 32989433›Full record

ArticleNeuro-oncology advances

Brain tumors and COVID-19: the patient and caregiver experience.

Mathew R Voisin, Kathy Oliver, Stuart Farrimond, Tess Chee, Jean Arzbaecher, Carol Kruchko, Mary Ellen Maher, Chris Tse, Rosemary Cashman, Maureen Daniels and 7 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Neurooncology: 2021 update.Free neuropathology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mathew R VoisinDivision of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-1191-9579
Kathy OliverInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Stuart FarrimondInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Tess CheeMcMaster University, Hamilton, Ontario, Canada.
Jean ArzbaecherInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Carol KruchkoInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Mary Ellen MaherInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Chris TseInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Rosemary CashmanInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Maureen DanielsInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Christine MungoshiInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Sharon LambInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Anita GraneroInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Mary LovelyInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Jenifer BakerInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Sally PayneInternational Brain Tumour Alliance (IBTA), Tadworth, UK.
Gelareh ZadehDivision of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince the COVID-19 pandemic began, thousands of medical procedures and appointments have been canceled or delayed. The long-term effects of these drastic measures on brain tumor patients and caregivers are unknown. The purpose of this study is to better understand how COVID-19 has affected this vulnerable population on a global scale.

methodsAn online 79-question survey was developed by the International Brain Tumour Alliance, in conjunction with the SNO COVID-19 Task Force. The survey was sent to more than 120 brain tumor charities and not-for-profits worldwide and disseminated to pediatric and adult brain tumor patients and caregivers. Responses were collected from April to May 2020 and subdivided by patient versus caregiver and by geographical region.

resultsIn total, 1989 participants completed the survey from 33 countries, including 1459 patients and 530 caregivers. There were no significant differences in COVID-19 testing rates (

conclusionsAs a result of COVID-19, brain tumor patients and caregivers have experienced significant stress and anxiety. We must continue to provide accessible high-quality care, information, and support in the age of COVID-19.

Indexed as

brain tumorcaregiversCOVID-19patientssurvey

Identifiers

PMID32989433
PMCPMC7499687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.